Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2012-04-04 Director's Dealing
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2012-04-04 English
OWNERSHIP DOCUMENT
Director's Dealing
2012-04-03 English
OWNERSHIP DOCUMENT
Director's Dealing
2012-04-02 English
RULE 424B5
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a securities offering. It details the terms of an offering of units consisting of common stock and warrants, including pricing, underwriting, and use of proceeds. The document references SEC registration numbers and includes detailed offering information, risk factors, and company background. This type of document is a capital raising disclosure, specifically a prospectus supplement for a securities offering, which fits the category of Capital/Financing Update (CAP). It is not an annual or quarterly report, earnings release, or any other report type. The length and content confirm it is a full offering document, not just an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2012-03-29 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes an underwriting agreement for a public offering of units consisting of common stock and warrants, including details about the offering price, terms, use of proceeds, and legal opinions. There are no financial statements or detailed financial performance data included, only an announcement of a financing event. The document is not an annual or quarterly report, audit report, earnings release, or management discussion. It is a regulatory filing announcing a capital raising event. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 9562 characters, which is sufficient to contain substantive information about the financing event, not just a brief announcement or a report publication notice. Hence, the confidence is high.
2012-03-29 English
RULE 424B5
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act, related to an offering of units consisting of common stock and warrants. It includes detailed information about the offering terms, underwriting, risk factors, use of proceeds, and company background. The document is a registration and offering prospectus supplement, which is a capital raising document describing securities issuance. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and financing activities. The document is not an annual or quarterly report, audit report, earnings release, or any other category. It is a detailed offering prospectus supplement related to capital raising.
2012-03-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.